|
1
|
Ke XY, Yu MX and Jiang M: Clinical
observation on treatment of rheumatoid arthritis with sinomenine.
Bei Jing Yi Xue. 8:186–188. 1986.
|
|
2
|
Satoh H: Electropharmacology of sinomeni
caulis et rhizome and its constituents in cardiomyocytes. Am J Chin
Med. 33:967–979. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vieregge B, Resch K and Kaever V:
Synergistic effects of the alkaloid sinomenine in combination with
the immunosuppressive drugs tacrolimus and mycophenolic acid.
Planta Medica. 65:80–82. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dai YB, Huang X and Luo ZG:
Immunosuppressive effect of sinomenine on ICAM-1 expression in rat
renal allograft rejection. Mod J Integr Trad Chin West Med.
12:1358–1363. 2003.
|
|
5
|
Chen W, Shen YD and Zhao GS: Inhibitory
effect of sinomenine on expression of cyclooxygenase-2 in
lipopolysaccharide-induced PC-12 cells. China J Chin Mat Medica.
29:900–903. 2004.PubMed/NCBI
|
|
6
|
Zhang Y, Wu M and Li XG: Experimental
study on the effect of selective COX-2 inhibitor sinomenine on HeLa
cells. Prog Mod Biomed. 6:38–40. 2006.
|
|
7
|
Hla T, Bishop-Bailey D, Liu CH, Schaefers
HJ and Trifan OC: Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem
Cell Biol. 31:551–557. 1999. View Article : Google Scholar
|
|
8
|
Morita I: Distinct functions of COX-1 and
COX-2. Prostaglandins Other Lipid Mediat. 68:165–175. 2002.
View Article : Google Scholar
|
|
9
|
Su JL, Shih JY, Yen ML, Jeng YM, Chang CC
and Hsieh CY: Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent
vascular endothelialgrowth factor-C up-regulation: a novel
mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res.
64:554–564. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soumaoro LT, Uetake H, Higuchi T, Takagi
Y, Enomoto M and Sugihara K: Cyclooxygenase-2 expression: a
significant prognostic indicator for patients with colorectal
cancer. Clin Cancer Res. 10:8465–8471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tucker ON, Danneberg AJ and Tang EK:
Cyclooxygenase-2 expression is up-regulated in human pancreatic
cancer. Cancer Res. 59:987–990. 1999.PubMed/NCBI
|
|
12
|
Timoshenko AV, Chakraborty C, Wagner GF
and Lala PK: COX-2-mediated stimulation of the lymphangiogenic
factor VEGF-C in human breast cancer. Br J Cancer. 94:1154–1163.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meric JB, Rottey S, Olaussen K, Soria JC,
Khayat D and Rixe O: Cyclooxygenase-2 as a target for anticancer
drug development. Crit Rev Oncol Hematol. 59:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dannenberg AJ and Subbaramaiah K:
Targeting cyclooxygenase-2 in human neoplasia: rationale and
promise. Cancer Cell. 4:431–436. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
|
|
16
|
Wagner AD, Grothe W, Haerting J, et al:
Combination chemotherapies in advanced gastric cancer: an updated
systematic review and meta-analysis. American Society of Clinical
Oncology. 25:45552007.
|
|
17
|
Chen CN, Sung CT, Lin MT, Lee PH and Chang
KJ: Clinicopathologic association of cyclooxygenase-1 and
cyclooxygenase-2 expression in gastric adenocarcinoma. Ann Surg.
233:183–188. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamaca D, Ayyildiz T, Coskun U, et al:
Cyclooxygenase-2 expression and its association with angiogenesis,
Helicobacter pylori, and clinicopathologic characteristics
of gastric carcinoma. Pathol Res Pract. 204:527–536. 2008.
View Article : Google Scholar
|
|
19
|
Tatsuguchi A, Matsui K and Shinji Y:
Cyclooxygenase-2 expression correlates with angiogenesis and
apoptosis in gastric cancer tissue. Hum Pathol. 35:488–495. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun WH, Yu Q, Shen H, et al: Roles of
Helicobacter pylori infection and cyclooxygenase-2
expression in gastric carcinogenesis. World J Gastroenterol.
10:2809–2813. 2004.PubMed/NCBI
|
|
21
|
Wang BH, Qian W and Gao YJ: Effects of
inhibition of cyclooxygenase-2 by RNA interference on proliferation
and apoptosis of human gastric cancer cells: an experimental study
with human gastric cancer cells and mice. Nat Med J China.
86:266–271. 2006.
|
|
22
|
Tjiu JW, Liao YH, Lin SJ, et al:
Cyclooxygenase-2 over-expression in human basal cell carcinoma cell
line increases antiapoptosis, angiogenesis, and tumorigenesis. J
Invest Dermatol. 126:1143–1151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fosien E: Biochemistry of cyclooxygenase
(COX-2) inhibitors and molecular pathology of COX-2 in neoplasia.
Crit Rev Las Sci. 37:431–502. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Willams CS and DuBois RN: Prostaglandin
endoperoxide synthase: why two isoforms? Am J Physiol. 270:393–400.
1996.PubMed/NCBI
|
|
25
|
Konturek PC, Hartwich A, Zuchowicz M, et
al: Helicobacter pylori gastrin and cyclooxygenases in
gastric cancer. J Physiol Pharmacol. 51:737–749. 2000.
|
|
26
|
Yu J, Leung WK, Chen J, Ebert MPA,
Malfertheiner P and Sung JJY: Expression of peroxisome
proliferators-activated receptor δ in human gastric cancer and its
response to specific COX-2 inhibitor. Cancer Lett. 223:11–17.
2005.
|
|
27
|
Da MX, Wu XT, Wang J, et al: Expression of
cyclooxygenase-2 and vascular endothelial growth factor-c
correlates with lymph-angiogenesis and lymphatic invasion in human
gastric cancer. Arch Med Res. 39:92–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tegeder I, Pfeilschifter J and Geisslinger
G: Cyclooxygenase-independent actions of cyclooxygenase inhibitors.
FASEB J. 15:2057–2072. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan XL, Chen L, Li MX, et al: Elevated
expression of Foxp3 in tumor-infiltrating Treg cells suppresses
T-cell proliferation and contributes to gastric cancer progression
in a COX-2-dependent manner. Clin Immunol. 134:277–288. 2010.
View Article : Google Scholar : PubMed/NCBI
|
